** ReNerve RNV.AX swells 98.8% to a record high of A$0.220; last up 40.9%
** Stock set for biggest ever intraday pct gain
** Medical devices maker says patients using its NervAlign® Nerve Cuff, which aids regeneration of peripheral nerves after surgery or injury, reported significantly lower post-surgery pain
** RNV set to end the quarter 11.4% lower
** About 4.5 mln shares traded in stock's busiest session ever
** RNV loses 5.7% YTD
(Reporting by Manasi Dasa Sundeep in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.